For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250521:nRSU6489Ja&default-theme=true
RNS Number : 6489J Smith & Nephew Plc 21 May 2025
SMITH & NEPHEW PLC
21 May 2025
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
This announcement is made in accordance with the UK Market Abuse Regulation
(Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the
European Union (Withdrawal) Act 2018).
1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2020
On 20 May 2025, the Company received notification of the following
transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew
plc (the "Company") following the vesting of awards under the Smith &
Nephew Global Share Plan 2020.
All figures in these columns are stated to 6 decimal places where applicable.
i. VESTING OF PERFORMANCE SHARE PLAN AWARDS MADE UNDER THE SMITH &
NEPHEW GLOBAL SHARE PLAN 2020
The awards were granted under the Global Share Plan 2020 and vested on 20 May
2025 at 59.35% of target. A number of Shares were sold to cover taxation
obligations arising on the vesting of the awards as detailed in the table
below. The number of Shares acquired includes the dividend equivalent Shares
which the participant received on the vested Shares. The table below sets
out the number of shares under award which vested. The remaining shares
under award have lapsed.
Reason for the notification
Initial notification /Amendment Initial notification
Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
Name Smith & Nephew plc
LEI 213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
Description of the financial instrument, type of instrument Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code ISIN: GB0009223206
Nature of the transaction Vesting on 20 May 2025 of Performance Share Plan awards granted under the
Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to
cover tax liability
Date of Transaction 2025 - 05 - 20
Place of Transaction London Stock Exchange (XLON)
Name Price (£) Volume Aggregated information
(Position) Status
Deepak Nath PDMR 10.875359 83,938 (of which 34,477 were sold and 49,461 were retained) N/A Single Transaction
(Chief Executive Officer)
ii. VESTING OF CONDITIONAL AWARDS MADE UNDER THE SMITH & NEPHEW GLOBAL
SHARE PLAN 2020
The awards were granted under the Global Share Plan 2020 and vested on 20 May
2025. A number of Shares were sold to cover taxation obligations arising on
the vesting of the awards as detailed in the table below.
The following relates to individuals included in the below notification:
Reason for the notification
Initial notification /Amendment Initial notification
Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
Name Smith & Nephew plc
LEI 213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
Description of the financial instrument, type of instrument Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code ISIN: GB0009223206
Nature of the transaction Vesting on 20 May 2025 of Conditional Share awards granted under the Smith
& Nephew Global Share Plan 2020, and subsequent sale of shares to cover
tax liability
Date of Transaction 2025 - 05 - 20
Place of Transaction London Stock Exchange (XLON)
Name Price (£) Volume Aggregated information
(Position) Status
Craig Gaffin PDMR 10.875359 1,551 (of which 379 were sold and 1,172 were retained) N/A Single Transaction
(President, Global Orthopaedics)
Elga Lohler PDMR 10.875359 20,174 (of which 8,026 were sold and 12,148 were retained) N/A Single Transaction
(Chief HR Officer)
Vasant Padmanabhan PDMR 10.875359 19,626 (of which 8,708 were sold and 10,918 were retained) N/A Single Transaction
(President Research & Development and ENT)
Rohit Kashyap PDMR 10.875359 11,949 (of which 2,920 were sold and 9,029 retained) N/A Single Transaction
(President, Advanced Wound Management and Global Commercial Operations)
Philip Horner
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFLFSVETILFIE